4ZEX

Crystal structure of PfHAD1 in complex with glyceraldehyde-3-phosphate

  • Classification: UNKNOWN FUNCTION
  • Organism(s): Plasmodium falciparum 3D7
  • Expression System: Escherichia coli BL21(DE3)
  • Mutation(s): Yes 

  • Deposited: 2015-04-20 Released: 2015-09-09 
  • Deposition Author(s): Park, J., Tolia, N.H.
  • Funding Organization(s): Children's Discovery Institue of Washington University and St. Louis Children's Hospital, National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID), Burroughs Wellcome Fund

Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.00 Å
  • R-Value Free: 0.221 
  • R-Value Work: 0.173 
  • R-Value Observed: 0.176 

Starting Model: experimental
View more details

wwPDB Validation   3D Report Full Report


Ligand Structure Quality Assessment 


This is version 1.5 of the entry. See complete history


Literature

Cap-domain closure enables diverse substrate recognition by the C2-type haloacid dehalogenase-like sugar phosphatase Plasmodium falciparum HAD1.

Park, J.Guggisberg, A.M.Odom, A.R.Tolia, N.H.

(2015) Acta Crystallogr D Biol Crystallogr 71: 1824-1834

  • DOI: https://doi.org/10.1107/S1399004715012067
  • Primary Citation of Related Structures:  
    4ZEV, 4ZEW, 4ZEX

  • PubMed Abstract: 

    Haloacid dehalogenases (HADs) are a large enzyme superfamily of more than 500,000 members with roles in numerous metabolic pathways. Plasmodium falciparum HAD1 (PfHAD1) is a sugar phosphatase that regulates the methylerythritol phosphate (MEP) pathway for isoprenoid synthesis in malaria parasites. However, the structural determinants for diverse substrate recognition by HADs are unknown. Here, crystal structures were determined of PfHAD1 in complex with three sugar phosphates selected from a panel of diverse substrates that it utilizes. Cap-open and cap-closed conformations are observed, with cap closure facilitating substrate binding and ordering. These structural changes define the role of cap movement within the major subcategory of C2 HAD enzymes. The structures of an HAD bound to multiple substrates identifies binding and specificity-determining residues that define the structural basis for substrate recognition and catalysis within the HAD superfamily. While the substrate-binding region of the cap domain is flexible in the open conformations, this region becomes ordered and makes direct interactions with the substrate in the closed conformations. These studies further inform the structural and biochemical basis for catalysis within a large superfamily of HAD enzymes with diverse functions.


  • Organizational Affiliation

    Department of Molecular Microbiology, Washington University School of Medicine, St Louis, MO 63110, USA.


Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
PfHAD1
A, B
296Plasmodium falciparum 3D7Mutation(s): 1 
Gene Names: PF10_0325
EC: 3.8.1
UniProt
Find proteins for Q8IJ74 (Plasmodium falciparum (isolate 3D7))
Explore Q8IJ74 
Go to UniProtKB:  Q8IJ74
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ8IJ74
Sequence Annotations
Expand
  • Reference Sequence
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.00 Å
  • R-Value Free: 0.221 
  • R-Value Work: 0.173 
  • R-Value Observed: 0.176 
  • Space Group: P 1 21 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 77.6α = 90
b = 44.6β = 101.3
c = 84.1γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
PHASERphasing
XDSdata reduction
XDSdata scaling
Blu-Icedata collection

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Children's Discovery Institue of Washington University and St. Louis Children's HospitalUnited StatesMD-LI-2011-171
National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)United StatesR01AI103280
Burroughs Wellcome FundUnited States1013514

Revision History  (Full details and data files)

  • Version 1.0: 2015-09-09
    Type: Initial release
  • Version 1.1: 2017-09-06
    Changes: Author supporting evidence, Derived calculations
  • Version 1.2: 2017-11-22
    Changes: Refinement description
  • Version 1.3: 2018-04-18
    Changes: Data collection, Database references
  • Version 1.4: 2019-12-11
    Changes: Author supporting evidence
  • Version 1.5: 2023-09-27
    Changes: Data collection, Database references, Derived calculations, Refinement description